We publish RMOC recommendations and resources, together with a host of other material for the benefit of our users.

A slide deck summarising SPS outputs and resources. It should be distributed to relevant healthcare professionals and their teams.
An overview of the changes to the requirements for medicines ‘safety features’ following the UK’s departure from the EU
A resource collating the latest medication safety communications and publications to inform, support and inspire medication safety improvements.
Template protocol for the administration of lidocaine 10mg/ml spray to facilitate intrauterine contraception (IUC) insertion or removal
This advisory statement is attached and has been prepared by the South RMOC for the South West and South East regions; and adopted by Midlands…
On behalf of the national RMOC system, RMOC (North) has led development of “Shared Care for Medicines Guidance – A Standard Approach” This guidance defines…
The Regional Medicines Optimisation Committee (RMOC, South) has produced standard principles for medicines prior approval forms which can be accessed below. The document provides advice…
Background This position statement and user guide have been approved by RMOC (London). The position statement includes a list of Rarely Used and Urgent Medicines.…
The July 2020 NHMC Newsletter contains a brief review of the homecare response to the COVID 19 pandemic including  a spotlight on one of the…
A slide deck summarising SPS outputs and resources. It should be distributed to relevant healthcare professionals and their teams.
A resource collating the latest medication safety communications and publications to inform, support and inspire medication safety improvements.
A list of new product evaluations that are freely available to NHS staff via the internet
E-learning developed by SPS in partnership with UKHSA, HEE and eLfH to support professionals who use, develop, authorise, review or update PGDs.
These are the detailed and easy read summary reports of the northern pharmacy technical services (PTS) workforce project. They provide a critical analysis of the…
SPS have developed a template audit tool to support organisations in auditing aspects of PGD development and use.
An audit tool based on the RPS Standards in Secure Environments is shared along with the national baseline audit undertaken in 2018
The below summary advises on the use of PGDs to supply or administer a medication which is part of a clinical trial, study or pilot
This paper lays down the system under which a pharmaceutical company wishing to supply medicinal products to the NHS hospital service is assessed if a…
This audit document is intended to be used to audit Pharmacy aspects of the safe administration of intrathecal chemotherapy, as part of the EL(97)52 Audit…